Idarubicin hydrochloride
What is Idarubicin hydrochloride?[edit | edit source]
Idarubicin hydrochloride (Idamycin PFS) a DNA-intercalating analog of daunorubicin used with other drugs to treat:
What are the uses of this medicine?[edit | edit source]
Idarubicin hydrochloride (Idamycin PFS) used with other drugs to treat:
- Acute myeloid leukemia (AML) in adults.
How does this medicine work?[edit | edit source]
- Idarubicin hydrochloride blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells.
- It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor.
- Also called 4-demethoxydaunorubicin.
- Idarubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis.
- The absence of a methoxy group at position 4 of the anthracycline structure gives high lipophilicity, idarubicin penetrates cell membranes more efficiently than other anthracycline antibiotic compounds Idarubicin Hydrochloride, Organic Chemical, Pharmacologic Substance
Who Should Not Use this medicine ?[edit | edit source]
- This medicine have no usage limitations.
What drug interactions can this medicine cause?[edit | edit source]
Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following:
- certain cancer chemotherapy medications such as daunorubicin (cerubidine), doxorubicin (Doxil), epirubicin (Ellence), mitoxantrone(Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin)
Is this medicine FDA approved?[edit | edit source]
How should this medicine be used?[edit | edit source]
Recommended dosage:
- Idarubicin hydrochloride injection 12 mg/m2 daily for 3 days by slow (10 to 15 min) intravenous injection in combination with cytarabine.
- The cytarabine may be given as 100 mg/m2 daily by continuous infusion for 7 days or as cytarabine 25 mg/m2 intravenous bolus followed by cytarabine 200 mg/m2 daily for 5 days continuous infusion.
Administration:
- Idarubicin comes as a solution (liquid) to be injected intravenously (into a vein) over 10 to 15 minutes by a doctor or nurse in a medical facility along with other chemotherapy medications.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- As Idarubicin Hydrochloride Injection available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only vials.
This medicine is available in fallowing brand namesː
- Idamycin PFS
What side effects can this medication cause?[edit | edit source]
The most common side effects of this medicine include:
- nausea
- vomiting
- diarrhea
- sores in the mouth and throat
- stomach pain
- headache
- joint pain
- hair loss
- rash
- redness and blisters on the palms and soles
What special precautions should I follow?[edit | edit source]
- Idarubicin Hydrochloride Injection should be given slowly into a freely flowing intravenous infusion. It must never be given intramuscularly or subcutaneously. Severe local tissue necrosis can occur if there is extravasation during administration.
- Idarubicin Hydrochloride can cause myocardial toxicity leading to congestive heart failure. Cardiac toxicity is more common in patients who have received prior anthracyclines or who have pre-existing cardiac disease.
- Severe myelosuppression occurs when idarubicin hydrochloride is used at effective therapeutic doses.
- It is recommended that idarubicin hydrochloride be administered only under the supervision of a physician who is experienced in leukemia chemotherapy and in facilities.
- Dosage should be reduced in patients with impaired hepatic or renal function. Frequent complete blood counts and monitoring of hepatic and renal function tests are recommended.
What to do in case of emergency/overdose?[edit | edit source]
Symptoms of overdosage may include:
- myelosuppression
- gastrointestinal toxicity
- acute cardiac toxicity
- mucositis
Management of overdosage:
* Adequate supportive care including platelet transfusions, antibiotics and symptomatic treatment of mucositis is required.
Can this medicine be used in pregnancy?[edit | edit source]
- There are no adequate and well-controlled studies in pregnant women.
- Women of childbearing potential should be advised to avoid pregnancy.
Can this medicine be used in children?[edit | edit source]
- Safety and effectiveness in pediatric patients have not been established.
What are the active and inactive ingredients in this medicine?[edit | edit source]
Active ingredients include:
- IDARUBICIN HYDROCHLORIDE
Inactive ingredients include:
- GLYCERIN
- HYDROCHLORIC ACID
- WATER
Who manufactures and distributes this medicine?[edit | edit source]
Manufactured by:
- THYMOORGAN PHARMAZIE GmbH,
- Schiffgraben 23, Goslar, Germany
Distributed by:
- West-Ward Pharmaceuticals
- Eatontown, NJ USA
What should I know about storage and disposal of this medication?[edit | edit source]
- Store under refrigeration 2° to 8°C (36° to 46°F), and protect from light.
- Retain in carton until time of use.
Idarubicin hydrochloride Resources | ||
---|---|---|
|
|
Idarubicin hydrochloride Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Deepika vegiraju